Alden H. Emery Β. R. Stanerson Dale B. Baker

Stanerson to Succeed Emery Board appoints Emery Honorary Secretary, as of July 1, to serve as consultant until 1966 retirement Dr. Alden H. Emery, Executive Sec­retary of the American Chemical Soci­ety for the past 18 years, will become Honorary Secretary of the Society on July 1, 1965, and the ACS Board of Directors has elected Dr. B. R. Staner­son, Deputy Executive Secretary since 1960, to succeed Dr. Emery as Execu­tive Secretary.

The change was approved at this time, according to Dr. Arthur C. Cope, Chairman of the ACS Board, because the Board would like to have Dr. Emery's successor serve at least one year before Dr. Emery's sched­uled retirement on July 1, 1966. Dur­ing this period, Dr. Emery will serve as an adviser and consultant.

As a result of another aministra-tive change voted by the Board at its Detroit meeting April 4, Dale B. Baker, Director of Chemical Abstracts Service, will report directly to the Board, starting July 1, 1965. He now reports to the Executive Secretary. Dr. Richard L. Kenyon, Director of ACS Publications, reports to the Board, so that after July 1 the heads of the three major areas of ACS activ­ity—the Executive Secretary's Office, the publications, and CAS—will be directly responsible to the Board.

Dr. Emery has been a member of the ACS staff since 1936, when he was appointed assistant manager un­der the late Dr. Charles L. Parsons, then secretary and business manager.

Dr. Emery was named assistant sec­retary in 1943 and succeeded Dr. Parsons when the latter retired at the end of 1945. His title became Exec­utive Secretary in 1947.

Under Dr. Emery's leadership, the Society has experienced phenomenal growth. When he became its admin­istrative head in 1946, ACS had 43,-000 members, 18 divisions, and 109 local sections. Today it has more than 100,000 members, 25 divisions, and 165 local sections.

Of all the activities under Dr. Emery's direction none has grown more rapidly than Chemical Abstracts Service, for which the Society will dedicate a new $6.8 million home at Columbus, Ohio, on June 3. With a staff of almost 600, the CAS operation has attained such magnitude that it has become increasingly difficult to supervise from ACS heaquarters in Washington. Under the new arrange­ment, this will no longer be necessary.

Dr. Emery came to ACS from the U.S. Bureau of Mines, where he was assistant chief engineer of the Experi­ment Station Division. He was born in New Hampshire in 1901 and re­ceived an A.B. magna cum laude from Oberlin College in 1922 and an A.M. from Ohio State University in 1923. He then joined the Bureau of Mines staff as a chemist in the Pittsburgh Experiment Station. He moved to the bureau's Washington office in 1927.

An ACS member since 1923, Dr. Emery was secretary of the Divi­sion of Gas and Fuel Chemistry from 1933 to 1937, an abstractor for Chem­ical Abstracts 1924-45, and an assist­ant editor of CA 1930-37.

Dr. Emery received the gold medal of the American Institute of Chemists in 1961 and an honorary D.Sc. from Dickinson College in 1957.

Dr. Stanerson, who was born in Iowa in 1907, received a B.S. in chemistry in 1930 and an M.S. in 1931 from Iowa State University. From 1931 to 1936 he taught chemistry and physics at Dowling College in Des Moines. He did graduate work in in­organic chemistry at Iowa State, earn­ing a Ph.D. in 1939.

For the next seven years, he was a project director at Texaco's Beacon, N.Y., research center.

Dr. Stanerson joined the ACS staff in 1947 and at various times was in charge of the National and Regional Employment Clearing Houses, the student affiliate program, and other education and manpower activities. He was named Director of Member­ship Affairs in 1958 and Deputy Ex­ecutive Secretary in 1960.

Mr. Baker was born in Ohio in 1920 and received a B.Ch.E. from Ohio State University in 1942. While at the university he worked for Chemical Abstracts as a student assistant. After four years with Du Pont, he returned to CA as an assistant editor, and re­sumed his studies at Ohio State, re­ceiving an M.S. in 1947.

Named associate editor of CA in 1952, Mr. Baker was appointed asso­ciate director of Chemical Abstracts Service in 1958. Later that year he succeeded Dr. E. J. Crane as director.

26 C&EN A P R I L 2 6, 1965

FDA Clears Oracon Sequential oral contraceptive on market

Mead Johnson's entry into the $40 mil­lion oral contraceptive business in the U.S. marks also the advent of a new product—a sequential oral contracep­tive. The company has started to market its sequential contraceptive (Oracon), following its clearance by the Food and Drug Administration. The Evansville, Ind., drug maker claims that Oracon largely avoids the undesirable side effects (nausea, ir­regular bleeding, and weight gain in some users) commonly associated with conventional oral contraceptives.

The sequential contraceptive differs from other oral contraceptives in the way the synthetic estrogen and pro­gestin hormones are taken. Using Oracon, a woman takes a tablet con­taining only an estrogen for the first 16 days of her menstrual cycle. She then takes a tablet that combines both the estrogen and a progestin for five days. With the earlier oral contraceptives, a single tablet containing both an estro­gen and a progestin is taken for 20 days. In either case, these hormones

Michigan Orders Time-Sharing Computer Will raise school's computer capacity eightfold

"Time-sharing" has penetrated aca­deme, specifically the University of Michigan, which has contracted with IBM for a System/360 Model 66. In­stallation is to begin in November 1966. Additional equipment will be installed in 1967, giving Michigan a dual system: two computers opera­ting either together or independently.

A time-sharing computer system di­vides its operating time (in millionths of seconds) on a rotating basis among many users. These users work simul­taneously on many kinds of problems that require varying computer func­tions. The time-sharing scheme will increase computer productivity six to eight times at the Ann Arbor campus.

Time-sharing has already been adopted by industry. Monsanto's IBM 7040 will begin using IBM's QUIKTRAN (a method by which us­ers keep track of their programs via

prevent conception by stopping ovula­tion. The estrogen in the Mead John­son product is ethinyl estradiol; the progestin is dimethisterone.

The present oral contraceptive mar­ket is dominated by G. D. Searle & Co.'s Enovid. Since Searle introduced Enovid in 1960, the sale of oral con­traceptives has grown by about 50% every year. Originally retailing at $11 for one month's supply, Enovid has become available in a lower dosage version at a retail price of about $2.25 a month. Mead Johnson says Oracon will be competitive with this price. Parke, Davis & Co., Syntex, Ortho Pharmaceutical Corp., and The Up­john Co. also market a "conventional" oral contraceptive.

Only 1.5% of women tested on Ora­con showed a weight gain of more than 5 pounds, compared with 13 to 19% with combination oral contracep­tives, Mead Johnson says. Also, first-cycle bleeding occurred only in 4.4% of those using Oracon, compared with up to 26% on regular pills, the com­pany adds.

Eli Lilly & Co., in conjunction with Syntex Laboratories, is also working on a sequential system. It has been sub­mitted to the Food and Drug Adminis­tration.

two-way communication with the com­puter) in a time-sharing technique, scheduled to begin in September (C&EN, March 22, page 40) . With remote computer input stations, Mon­santo scientists and engineers will be able to develop and carry out their own programs on the 7040 without leaving their laboratories and offices.

Similarly, up to 200 students, fac­ulty, and research personnel at Michi­gan will have access to the System/ 360 at their fingertips via remote ter­minals located in classrooms, offices, and laboratories. The MAD (Michi­gan algorithm decoder) language and a set of computer instructions called the Michigan executive system will be converted for time-sharing.

The university decided to set up the time-sharing system after a faculty committee (headed by Dr. Donald L. Katz of the chemical and metallurgical engineering faculty) reviewed future computer needs and instructional re­quirements. The present computer system on the campus is used 24 hours each day, handling up to 1000 prob­lems a day.

Spaght to Be Proposed As Shell Oil chairman Chemist Monroe E. Spaght is the likely successor to John H. Loudon as board chair­man of Shell Oil and managing di­rector of Royal Dutch Petroleum Co. Dr. Spaght will be proposed for election to both offices, Shell Oil revealed last week in New York. Mr. Loudon retires from both posts July 1. Dr. Spaght has been president of Shell Oil since Jan. 1, 1961. He received his Ph.D. from Stanford and joined Shell in 1933. He became president of Shell Develop­ment in 1949 and executive v.p. of Shell Oil in 1953.

Polybutadiene Patent Under Fire in Courts Phillips Petroleum's new composition-of-matter patent covering cis-l,4-poly-butadiene is now in the courts. Last week, Goodrich-Gulf brought action in the U.S. District Court for the Northern District of Ohio challenging the validity of the patent (U.S. 3,178,-402) which had issued to Phillips on April 13 (C&EN, April 19, page 19).

Goodrich-Gulf says it hopes for an early trial to finally determine the is­sues in the patent. Three compa­nies—Phillips, Goodrich-Gulf, and Monsanto—had been involved in Pat­ent Office interference over certain re­lated issues in applications filed by these companies.

A spokesman for Monsanto says that "We have no commercial poly­butadiene operation, and did not feel it necessary to file a civil suit. Inter­ference action continuing in the Pat­ent Office will, we, feel, substantiate our claim to prior invention."

Phillips declines to comment on the court action or the patent. The com­pany says it announced the invention of cis-polybutadiene in 1956 and be­gan production in 1959. It has li­censed its process to four foreign and three U.S. firms, one of which is Gen­eral Tire.

Goodrich-Gulf has foreign patents in the polybutadiene area. It has eight licensees for patents, and/or knowledge. One of the licensees is in the U.S.

A P R I L 26, 1965 C & E N 27